{"name":"CureLab Oncology","slug":"curelab-oncology","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ELENAGEN","genericName":"ELENAGEN","slug":"elenagen","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ELENAGEN","genericName":"ELENAGEN","slug":"elenagen","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNT1Z3SWdreC1Vb1MxVzFaUFJGa0hpOUVfZFBmOUlEbjVZR3FxZC1RYlhOd2pJZlY2LW8zYXVRUVZURGUyQlJvZ2cxT0c5Z2pCSHk4TnFXckxSZFc3bXJxODUxMjRjX2dFNzB4a1hrdkxLVnZBdk45NVZrSlEwS05aMEdobw?oc=5","date":"2026-02-13","type":"pipeline","source":"pharmaphorum","summary":"New hope for ovarian cancer, with Alexander Schneider - pharmaphorum","headline":"New hope for ovarian cancer, with Alexander Schneider","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNRUphdGJKUktMMUNWcmRDdjZ2Yy1UN1U2MEk4WTBlLWtUeHNIUWRETktDZVU0RzJtb0hTRXZibGNMZ2JJRmlRVEpBVS0tMGVXTllfb3k4Y3BrLVVZdWc4UkNjLVlMSmZFVlBLQnF5Z1hJSVJIYm9TdXZkSUtqdEg3RjVJMVBWeGhBQkpsd1J1amFVcHowZ2tlaw?oc=5","date":"2025-05-05","type":"pipeline","source":"Labiotech.eu","summary":"Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic - Labiotech.eu","headline":"Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOM3hjRHdCcTRJaGtTV3o5UXEzZEo5Tk56MXRDbmVhOWRxaXN6TzZKZHNiU2pFRjNuM3ZiSXdfZVRLSXNfLW5BckFKZ3FRam9weEM2eWxndlAwRzkwcVNCRWJfZGtybmtfMzBRdlFwOTZ5NTVtODhQSlVxMFVMSU16S0Q3RzYyR2Z4cFVMOWVhRGJrbVRXVnV4SkpYYjdtTC1LQ0dQcnB1LXhnY1ZqTUF3RlZIT3hQNXQ2V0JJZFF0R2xlYk13QXc?oc=5","date":"2024-07-11","type":"pipeline","source":"PR Newswire","summary":"CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief Medical Officer - PR Newswire","headline":"CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQa2s3LVhPendUMXU1WUVPdTU2c2hQemNFY2JGcmhraXhYU0xzYU1mVmFHb3d1aTdlOHd1MDVlclotRFk5MUFvUU8ySzBlcVZwOGQxZUtvdFhtckRPSlpGbXlHZU9jZTE2Rnd6VFhjT1RJWUxyNDdKRkpHdVI4djVfZjdNSFRRbEt4SXh3cW1SSUpURGpydzh3OWZaTFJKS0RaNEI4NHpZSG16elZtbkdGX1JPZ3JRY1cyOXBkSHdR?oc=5","date":"2022-10-17","type":"pipeline","source":"BioPharma APAC","summary":"CureLab to address the growing burden of cancer in APAC : Dr. Alexander Shneider - BioPharma APAC","headline":"CureLab to address the growing burden of cancer in APAC : Dr. Alexander Shneider","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxNMXJlMUtMRmpka21FTXNyMi1zMEgyTTlmajlTS1lqanYySU9Ub3ZPQXlyVzZUTmd5SHVTZFVoRHVDTXc2Ylk5OEV3Ny02eEpLZzJra0dQQmtqTGg1Q3JSUTZldWtTQlJrcmhjY3NMdW90bV9SQ0hjd0xHeDhvOFJ1UC1OcGQ5dzF0QzVSS0czLWtySUd2bjVYckxDV1RxU0tqRzM0bS1OdjduamNqSnotUk41WXhCcnRvb0tzLXJpOGNwSEowQ0dHYUhvMDVRUFgtOWVsRlJNRzQ5MXVPT1FlUUtQbC1KRlpiVm9DVTBnOXdKV1pCVndzdm9GdWVYcGdRU1F3dlltY0RtQ19iNkNVaDFrc1BWbVJpVDIxdHVkOVFIeU5xM0tBUTZvdG5DMk1OM01XS21sdGxnaVdsMzhGUENHbw?oc=5","date":"2022-09-09","type":"pipeline","source":"PR Newswire","summary":"ESMO 2022: Interim Results for Treatment of Platinum-Resistant Ovarian Cancer with p62 Plasmid DNA Show Statistically Significant Changes in Progression-Free Survival - PR Newswire","headline":"ESMO 2022: Interim Results for Treatment of Platinum-Resistant Ovarian Cancer with p62 Plasmid DNA Show Statistically Si","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNYXhJZHN2el9LY1lyaE5uREVfMDVlTHpQWEVTYjFHdXYzQWJkS0lJWTBvRFRCVEp6aXQ3YUJLa3c2aVBtVnRqR1Z5T3Q4U2ZrWU5ZQTFDUnNORjlTSXdkWkVIVUI5YnpjQ1Z3NWZhLWdhWi1BdkFLN2xmQXl1bU1jREI3NWZtVnVUNjdpdDhQUDJxeG9qSHE0WlJqOA?oc=5","date":"2020-01-09","type":"pipeline","source":"Bioprocess Online","summary":"A Disruptive Approach To Oncology Therapy Development - Bioprocess Online","headline":"A Disruptive Approach To Oncology Therapy Development","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}